Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qiyue Hu

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Antimicrobial Agents and Chemotherapy|May 23, 2007
Diphenyl furans and aza analogs: effects of structural modification on in vitro activity, DNA binding, and accumulation and distribution in trypanosomesAmanda M Mathis, Arlene S Bridges, Mohamed A Ismail, et al.
Journal of Medicinal Chemistry|October 31, 2009
Azaindole hydroxamic acids are potent HIV-1 integrase inhibitorsMichael B Plewe, Scott L Butler, Klaus R Dress, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Highly Selective and Potent Thiophenes as PI3K Inhibitors with Oral Antitumor ActivityKevin K-C Liu, JinJiang Zhu, Graham L Smith, et al.
Journal of Medicinal Chemistry|October 13, 2021
Discovery of 2-(Ortho-Substituted Benzyl)-Indole Derivatives as Potent and Orally Bioavailable RORγ Agonists with Antitumor ActivityBiao Lu, Dong Liu, Bin Gui, et al.
European Journal of Medicinal Chemistry|December 15, 2021
Discovery of spiro amide SHR902275: A potent, selective, and efficacious RAF inhibitor targeting RAS mutant cancersPeng Zhao, Linghang Zhuang, Xiangzhu Wang, et al.
Journal of Computer-Aided Molecular Design|May 24, 2011
Design of a multi-purpose fragment screening library using molecular complexity and orthogonal diversity metricsWan F Lau, Jane M Withka, David Hepworth, et al.
Bioorganic & Medicinal Chemistry Letters|November 2, 2010
Azaindole N-methyl hydroxamic acids as HIV-1 integrase inhibitors-II. The impact of physicochemical properties on ADME and PKSteven P Tanis, Michael B Plewe, Ted W Johnson, et al.
Journal of Medicinal Chemistry|March 31, 2011
Design and synthesis of novel N-hydroxy-dihydronaphthyridinones as potent and orally bioavailable HIV-1 integrase inhibitorsTed W Johnson, Steven P Tanis, Scott L Butler, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 2010
4-methylpteridinones as orally active and selective PI3K/mTOR dual inhibitorsKevin K-C Liu, Shubha Bagrodia, Simon Bailey, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Antimicrobial Agents and Chemotherapy|May 23, 2007
Diphenyl furans and aza analogs: effects of structural modification on in vitro activity, DNA binding, and accumulation and distribution in trypanosomesAmanda M Mathis, Arlene S Bridges, Mohamed A Ismail, et al.
Journal of Medicinal Chemistry|October 31, 2009
Azaindole hydroxamic acids are potent HIV-1 integrase inhibitorsMichael B Plewe, Scott L Butler, Klaus R Dress, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Highly Selective and Potent Thiophenes as PI3K Inhibitors with Oral Antitumor ActivityKevin K-C Liu, JinJiang Zhu, Graham L Smith, et al.
Journal of Medicinal Chemistry|October 13, 2021
Discovery of 2-(Ortho-Substituted Benzyl)-Indole Derivatives as Potent and Orally Bioavailable RORγ Agonists with Antitumor ActivityBiao Lu, Dong Liu, Bin Gui, et al.
European Journal of Medicinal Chemistry|December 15, 2021
Discovery of spiro amide SHR902275: A potent, selective, and efficacious RAF inhibitor targeting RAS mutant cancersPeng Zhao, Linghang Zhuang, Xiangzhu Wang, et al.
Journal of Computer-Aided Molecular Design|May 24, 2011
Design of a multi-purpose fragment screening library using molecular complexity and orthogonal diversity metricsWan F Lau, Jane M Withka, David Hepworth, et al.
Bioorganic & Medicinal Chemistry Letters|November 2, 2010
Azaindole N-methyl hydroxamic acids as HIV-1 integrase inhibitors-II. The impact of physicochemical properties on ADME and PKSteven P Tanis, Michael B Plewe, Ted W Johnson, et al.
Journal of Medicinal Chemistry|March 31, 2011
Design and synthesis of novel N-hydroxy-dihydronaphthyridinones as potent and orally bioavailable HIV-1 integrase inhibitorsTed W Johnson, Steven P Tanis, Scott L Butler, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 2010
4-methylpteridinones as orally active and selective PI3K/mTOR dual inhibitorsKevin K-C Liu, Shubha Bagrodia, Simon Bailey, et al.
Pageof 5